VALIANT LABORATORIES
Back to All Ratios
|
VALIANT LABORATORIES Last 5 Year Payable days History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Payable days | 79.77 | 62.43 |
What is the latest Payable days ratio of VALIANT LABORATORIES ?
Year | Payable days |
---|---|
Mar2024 | 79.77 |
Mar2023 | 62.43 |
How is Payable days of VALIANT LABORATORIES Trending?
Years | Payable days | % Change | |
---|---|---|---|
Mar2024 | 79.77 | 27.78 | |
Mar2023 | 62.43 | - |
Other Financial Ratios of VALIANT LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Payable days ratio of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹453.9 Cr | -3.4% | -5.3% | -19.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -3.4% |
-5.3% |
-19.3% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses